Evidence map›Paper›PMID 39914554›Full record

ArticleThe Journal of allergy and clinical immunology2025

Clinical, immunologic, and genetic characteristics of 148 patients with natural killer cell deficiency.

Manar Abdalgani, Evelyn R Hernandez, Luis A Pedroza, Ivan K Chinn, Lisa R Forbes Satter, Nicholas L Rider, Pinaki P Banerjee, M Cecilia Poli, Sanjana Mahapatra, Debra Canter and 8 more

Abstract read
In one paragraph

Article in The Journal of allergy and clinical immunology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors.

Manar AbdalganiDepartment of Pediatrics, Columbia University Vagelos College of Physicians and Surgeons, Columbia University, New York, NY.
Evelyn R HernandezDepartment of Pediatrics, Columbia University Vagelos College of Physicians and Surgeons, Columbia University, New York, NY.
Luis A PedrozaDepartment of Pediatrics, Columbia University Vagelos College of Physicians and Surgeons, Columbia University, New York, NY.
Ivan K ChinnDepartment of Pediatrics, Baylor College of Medicine, Houston, Tex; Texas Children's Hospital, Houston, Tex.
Lisa R Forbes SatterDepartment of Pediatrics, Baylor College of Medicine, Houston, Tex; Texas Children's Hospital, Houston, Tex.
Nicholas L RiderDepartment of Health Systems & Implementation Science, Virginia Tech Carilion School of Medicine, Blacksburg, Va; Section of Allergy-Immunology, The Carilion Clinic, Roanoke, Va.
Pinaki P BanerjeeUniversity of Texas MD Anderson Cancer Center, Houston, Tex.
M Cecilia PoliFaculty of Medicine, Clinica Alemana Universidad del Desarrollo, Santiago, Chile.
Sanjana MahapatraDepartment of Pediatrics, Baylor College of Medicine, Houston, Tex.
Debra CanterDepartment of Pediatrics, Baylor College of Medicine, Houston, Tex; Texas Children's Hospital, Houston, Tex.
Tram CaoDepartment of Pediatrics, Baylor College of Medicine, Houston, Tex; Texas Children's Hospital, Houston, Tex.
Linda M ShawverThe Children's Hospital of Philadelphia, Philadelphia, Pa.
Sarada L NandiwadaDepartment of Pediatrics, Baylor College of Medicine, Houston, Tex; Texas Children's Hospital, Houston, Tex.
James R LupskiMolecular and Human Genetics, Baylor College of Medicine, Houston, Tex; Human Genome Sequencing Center, Baylor College of Medicine, Houston, Tex; Texas Children's Hospital, Houston, Tex.
Jennifer E PoseyDepartment of Pediatrics, Baylor College of Medicine, Houston, Tex; Molecular and Human Genetics, Baylor College of Medicine, Houston, Tex.
Rajasekhar RamakrishnanDepartment of Pediatrics, Columbia University Vagelos College of Physicians and Surgeons, Columbia University, New York, NY.
Emily M MaceDepartment of Pediatrics, Columbia University Vagelos College of Physicians and Surgeons, Columbia University, New York, NY.
Jordan S OrangeDepartment of Pediatrics, Columbia University Vagelos College of Physicians and Surgeons, Columbia University, New York, NY. Electronic address: jso2121@cumc.columbia.edu.

Funding

Frequency of variants of unknown significance by ancestry groups in the All of Us Research Program cohortU01HG011758 · NHGRI · BAYLOR COLLEGE OF MEDICINE · PI RICHARD A GIBBS, JAMES R. LUPSKI · 2021 to 2026
$13.8M
GENETIC, IMMUNOLOGIC AND MECHANISTIC BASIS OF HUMAN NK CELL DEFICIENCYR01AI120989 · NIAID · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI ORANGE, JORDAN SCOTT · 2016 to 2025
$7.7M
Directing Function at the Natural Killer Cell Secretory Immunological SynapseR01AI067946 · NIAID · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI ORANGE, JORDAN SCOTT · 2007 to 2019
$4.8M
DETERMINING THE ROLE OF THE REPLICATIVE HELICASE IN HUMAN NK CELL DEVELOPMENTR01AI137275 · NIAID · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI MACE, EMILY MARGARET · 2018 to 2022
$1.9M
Directing Function at the Natural Killer Cell Secretory Immunological SynapseR37AI067946 · NIAID · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI Jordan Scott Orange · 2024 to 2026
$1.5M
NHGRI NIH HHS U01 HG011758NIAID NIH HHS R01 AI067946NIAID NIH HHS R01 AI120989NIAID NIH HHS R01 AI137275NIAID NIH HHS R37 AI067946
6 · The paper itself

Abstract

backgroundNatural killer (NK) cell deficiency (NKD) is an immunodeficiency phenotype in which abnormality of NK cells is the major clinically relevant immune defect.

objectiveWe sought to define the clinical, immunologic, and genetic characteristics of patients with NKD to aid in the understanding of these individuals and this cell type and guide future research and clinical practice.

methodsDuring 2006-2022, 168 individuals with a suspected diagnosis of NKD were enrolled, with comprehensive clinical, immunologic, and genetic data collected and analyzed. Research exome sequencing was performed to identify both known and novel genetic associations.

resultsNK cell abnormalities consistent with NKD were confirmed in 148 participants. Most presented during childhood (median age 13 years, range 0-76 years), though 34% were adults. All tested individuals exhibited reduced NK cell cytotoxic function; 44% also had decreased NK cell numbers and/or mature NK cells. Herpesvirus and/or papillomavirus infections were observed in 71%, malignancies were observed in 7%, and a 5% case-fatality rate was noted. Among the 99 participants who underwent research exome sequencing, 29% were considered solved for a likely contributing variant allele, with 52% of these cases involving known genes and 48% involving novel genes.

conclusionsNKD is a phenotypic immunodeficiency associated with increased susceptibility to certain viral infections and cancer with multiple genetic etiologies, revealing key biological pathways for NK cell development and function. This research underscores the role of NK cells in human immune defenses and helps advance the identification of at-risk populations, precise genetic diagnoses, and informed clinical management for patients with NKD.

Indexed as

Immunologic Deficiency SyndromesKiller Cells, NaturalAdolescentAdultAgedChildChild, PreschoolExome SequencingFemaleHumansInfantInfant, NewbornMaleMiddle AgedYoung Adultcytotoxicity, immunogeneticsgene pathogenic allelesherpesvirusinborn errors of immunityNK cellsprimary immunodeficiency

Identifiers

PMID39914554
PMCPMC12058391

What Socratic holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.